Search research articles
Contact Us
Filters
Showing results (61-70 of 93) with videos related to
Page
of 10
Sort By:
Gut
|
March 1, 1996
Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases
B S Nielsen, N Borregaard, J R Bundgaard, et al.
British Journal of Cancer
|
July 1, 1990
Transport of the multidrug resistance modulators verapamil and azidopine in wild type and daunorubicin resistant Ehrlich ascites tumour cells
M Sehested, T Skovsgaard, P B Jensen, et al.
FEBS Letters
|
October 18, 2000
N-terminal and core-domain random mutations in human topoisomerase II alpha conferring bisdioxopiperazine resistance
L H Jensen, I Wessel, M Møller, et al.
Histopathology
|
August 2, 2008
Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma
L Marquard, L M Gjerdrum, Ib J Christensen, et al.
Cancer Research
|
October 23, 1997
Loss of amino acids 1490Lys-Ser-Lys1492 in the COOH-terminal region of topoisomerase IIalpha in human small cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localization
I Wessel, P B Jensen, J Falck, et al.
International Journal of Cancer
|
January 3, 1996
92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer
B S Nielsen, S Timshel, L Kjeldsen, et al.
British Journal of Cancer
|
July 4, 1998
Immunohistochemical detection of DNA topoisomerase IIalpha, P-glycoprotein and multidrug resistance protein (MRP) in small-cell and non-small-cell lung cancer
J Kreisholt, M Sorensen, P B Jensen, et al.
Biochemical Pharmacology
|
August 3, 1993
Antagonistic effect of the cardioprotector (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) on DNA breaks and cytotoxicity induced by the topoisomerase II directed drugs daunorubicin and etoposide (VP-16)
M Sehested, P B Jensen, B S Sørensen, et al.
British Journal of Cancer
|
December 1, 1989
Inhibition of vincristine binding to plasma membrane vesicles from daunorubicin-resistant Ehrlich ascites cells by multidrug resistance modulators
M Sehested, P B Jensen, T Skovsgaard, et al.
Cancer Research
|
June 1, 1994
Targeting the cytotoxicity of topoisomerase II-directed epipodophyllotoxins to tumor cells in acidic environments
P B Jensen, B S Sørensen, M Sehested, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 93) with videos related to
Sort By:
Page
of 10
Gut
|
March 1, 1996
Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases
B S Nielsen, N Borregaard, J R Bundgaard, et al.
British Journal of Cancer
|
July 1, 1990
Transport of the multidrug resistance modulators verapamil and azidopine in wild type and daunorubicin resistant Ehrlich ascites tumour cells
M Sehested, T Skovsgaard, P B Jensen, et al.
FEBS Letters
|
October 18, 2000
N-terminal and core-domain random mutations in human topoisomerase II alpha conferring bisdioxopiperazine resistance
L H Jensen, I Wessel, M Møller, et al.
Histopathology
|
August 2, 2008
Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma
L Marquard, L M Gjerdrum, Ib J Christensen, et al.
Cancer Research
|
October 23, 1997
Loss of amino acids 1490Lys-Ser-Lys1492 in the COOH-terminal region of topoisomerase IIalpha in human small cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localization
I Wessel, P B Jensen, J Falck, et al.
International Journal of Cancer
|
January 3, 1996
92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer
B S Nielsen, S Timshel, L Kjeldsen, et al.
British Journal of Cancer
|
July 4, 1998
Immunohistochemical detection of DNA topoisomerase IIalpha, P-glycoprotein and multidrug resistance protein (MRP) in small-cell and non-small-cell lung cancer
J Kreisholt, M Sorensen, P B Jensen, et al.
Biochemical Pharmacology
|
August 3, 1993
Antagonistic effect of the cardioprotector (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) on DNA breaks and cytotoxicity induced by the topoisomerase II directed drugs daunorubicin and etoposide (VP-16)
M Sehested, P B Jensen, B S Sørensen, et al.
British Journal of Cancer
|
December 1, 1989
Inhibition of vincristine binding to plasma membrane vesicles from daunorubicin-resistant Ehrlich ascites cells by multidrug resistance modulators
M Sehested, P B Jensen, T Skovsgaard, et al.
Cancer Research
|
June 1, 1994
Targeting the cytotoxicity of topoisomerase II-directed epipodophyllotoxins to tumor cells in acidic environments
P B Jensen, B S Sørensen, M Sehested, et al.
Page
of 10